Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Beta-d-mannopyranosyl-(1->4) With Alpha-d-galactopyranosyl Branch Through (1->6) Linkage
2. D-galacto-d-mannan, Phosphate
3. Davanat
4. Galactomannan C
5. Galactomannan Type I
6. Galactomannan Type Ii
7. Galactomannan, Phosphate
8. Gm-ct-01
9. Peptidophosphogalactomannan
10. Phosphogalactomannan
1. Galactomannoglycan
2. Carob Galactomannan
3. 11078-30-1
4. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol
5. C00883
6. Ac1l975n
7. D-galacto-d-mannane
8. Schembl19799345
9. Chebi:27680
10. Zinc8216558
11. W-200825
12. 6-o-alpha-d-galactopyranosyl-4-o-beta-d-mannopyranosyl-beta-d-mannopyranose
13. Wurcs=2.0/2,3,2/[a1122h-1b_1-5][a2112h-1a_1-5]/1-1-2/a4-b1_a6-c1
14. (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methoxy]tetrahydropyran-3,4,5-triol
| Molecular Weight | 504.4 g/mol |
|---|---|
| Molecular Formula | C18H32O16 |
| XLogP3 | -6.3 |
| Hydrogen Bond Donor Count | 11 |
| Hydrogen Bond Acceptor Count | 16 |
| Rotatable Bond Count | 7 |
| Exact Mass | 504.16903493 g/mol |
| Monoisotopic Mass | 504.16903493 g/mol |
| Topological Polar Surface Area | 269 Ų |
| Heavy Atom Count | 34 |
| Formal Charge | 0 |
| Complexity | 641 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 15 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
ABOUT THIS PAGE
A Galactomannan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Galactomannan, including repackagers and relabelers. The FDA regulates Galactomannan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Galactomannan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Galactomannan supplier is an individual or a company that provides Galactomannan active pharmaceutical ingredient (API) or Galactomannan finished formulations upon request. The Galactomannan suppliers may include Galactomannan API manufacturers, exporters, distributors and traders.
click here to find a list of Galactomannan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Galactomannan DMF (Drug Master File) is a document detailing the whole manufacturing process of Galactomannan active pharmaceutical ingredient (API) in detail. Different forms of Galactomannan DMFs exist exist since differing nations have different regulations, such as Galactomannan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Galactomannan DMF submitted to regulatory agencies in the US is known as a USDMF. Galactomannan USDMF includes data on Galactomannan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Galactomannan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Galactomannan suppliers with USDMF on PharmaCompass.
Galactomannan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Galactomannan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Galactomannan GMP manufacturer or Galactomannan GMP API supplier for your needs.
A Galactomannan CoA (Certificate of Analysis) is a formal document that attests to Galactomannan's compliance with Galactomannan specifications and serves as a tool for batch-level quality control.
Galactomannan CoA mostly includes findings from lab analyses of a specific batch. For each Galactomannan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Galactomannan may be tested according to a variety of international standards, such as European Pharmacopoeia (Galactomannan EP), Galactomannan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Galactomannan USP).
LOOKING FOR A SUPPLIER?
